1. AB0846 Personalising care: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is a cost effective strategy in spondyloarthritis. (12th June 2018) Authors: Dubash, S.; Bryer, D.; Fitton, J.; Barr, A.; Vandevelde, C.; Marzo-Ortega, H.; Freeston, J. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Osteoradionecrosis rates in patients receiving radical radiotherapy for head and neck cancer at the Royal United Hospital Bath. (October 2019) Authors: Wade, L.; Fitton, J.; Colbert, S.; De Winton, E. Journal: Clinical oncology Issue: Volume 31(2019)Supplement 1 Page Start: e3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0175 REAL-WORLD EXPERIENCE OF SWITCHING FROM ORIGINATOR TO BIOSIMILAR RITUXIMAB IN RHEUMATOID ARTHRITIS. (2nd June 2020) Authors: Melville, A.; MD Yusof, M. Y.; Fitton, J.; Bailey, L.; Emery, P.; Buch, M. H.; Dass, S.; Saleem, B. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗